Skip to main content
Back to Mitsubishi UFJ Capital

Mitsubishi UFJ Capital's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Mitsubishi UFJ Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$123.9M

Therapeutics Portfolio Companies (3)

Export
BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Kyoto, Japan
December 2024
$955K
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

South San Francisco, United States
August 2024
$68.0M
Series A

Founder Contacts

19,000+ verified contacts

Explore Mitsubishi UFJ Capital's Full Portfolio

View all companies funded by Mitsubishi UFJ Capital across every industry and funding stage.

View Full Mitsubishi UFJ Capital Portfolio